Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DTYMK | P23919 | 4/20 | 0.38 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.38 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.38 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.38 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20224913 | 0.92 | DTYMK (0.38) | DTYMKP2RX1P2RX3P2RX4RNASEL | |
| SCHEMBL20224825 | 0.87 | DTYMK (0.40) | DTYMKRNASEL | |
| SCHEMBL22990422 | 0.86 | RNASEL (0.43) | DTYMKP2RX1P2RX3P2RX4RNASEL | |
| SCHEMBL20224826 | 0.84 | DNPH1 (0.39) | DTYMKRNASEL | |
| SCHEMBL22990366 | 0.84 | RNASEL (0.45) | DTYMKRNASEL | |
| SCHEMBL20325355 | 0.80 | POLB (0.44) | DTYMKP2RX1P2RX3P2RX4STING1 | |
| SCHEMBL20225032 | 0.80 | DTYMK (0.43) | DTYMKRNASEL | |
| SCHEMBL21298878 | 0.77 | P2RX3 (0.47) | P2RX1P2RX3P2RX4 | |
| SCHEMBL20325328 | 0.77 | P2RX3 (0.47) | P2RX1P2RX3P2RX4 | |
| SCHEMBL20224912 | 0.77 | FHIT (0.44) | DTYMKP2RX1P2RX3P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018100558-A2 | CYCLIC DINUCLEOTIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-07 | — | — | WO | disclosed |